Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer.
暂无分享,去创建一个
M. Pelizzo | D. Rubello | M. Agostini | D. Nitti | G. Pennelli | M. Enzo | P. Del Bianco | A. Saccani | M. Zane | E. Casal Ide | F. Torresan | I. Merante Boschin
[1] N. Fortunati,et al. Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer , 2012, Front. Endocrin..
[2] K. Pantel,et al. Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.
[3] S. Franceschi,et al. Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. , 2012, Thyroid : official journal of the American Thyroid Association.
[4] J. Tabernero,et al. Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer. , 2011, Future oncology.
[5] V. de Giorgi,et al. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[6] Z. Barekati,et al. Cell-free DNA in the circulation as a potential cancer biomarker. , 2011, Anticancer research.
[7] Klaus Pantel,et al. Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.
[8] Y. Nikiforov. Molecular diagnostics of thyroid tumors. , 2011, Archives of pathology & laboratory medicine.
[9] C. Nucera,et al. BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. , 2011, Cancer research.
[10] E. Urso,et al. Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy , 2011, Annals of Surgical Oncology.
[11] A. Toniato,et al. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience , 2011, Clinical chemistry and laboratory medicine.
[12] K. Jung,et al. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[13] M. Fournier,et al. A need for basic research on fluid-based early detection biomarkers. , 2010, Cancer research.
[14] M. Brandi,et al. Thyroid Cancer: Current Molecular Perspectives , 2010, Journal of oncology.
[15] M. Xing,et al. Recent advances in molecular biology of thyroid cancer and their clinical implications. , 2008, Otolaryngologic clinics of North America.
[16] S. Filetti,et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. , 2007, The Journal of clinical endocrinology and metabolism.
[17] J. Minna,et al. Methods for detecting DNA methylation in tumors: from bench to bedside. , 2007, Cancer letters.
[18] P. Vineis,et al. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. , 2007, Mutation research.
[19] M. Xing,et al. Gene methylation in thyroid tumorigenesis. , 2007, Endocrinology.
[20] J. Califano,et al. Increased plasma DNA integrity index in head and neck cancer patients , 2006, International journal of cancer.
[21] J. Califano,et al. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer , 2006, International journal of cancer.
[22] A. Giuliano,et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] H. Reber,et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. , 2006, Clinical chemistry.
[24] S. Asa,et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.
[25] V. Ganapathy,et al. Biological functions of SLC5A8, a candidate tumour suppressor. , 2005, Biochemical Society transactions.
[26] C. Marshall,et al. B-RAF is a therapeutic target in melanoma , 2004, Oncogene.
[27] D. Elashoff,et al. Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome , 2004, Cancer Research.
[28] D. Hoon,et al. Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility , 2004, Annals of the New York Academy of Sciences.
[29] D. Hoon,et al. Circulating nucleic acids in plasma and serum: past, present and future. , 2004, Current opinion in molecular therapeutics.
[30] R. Elashoff,et al. Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma. , 2004, Journal of the National Cancer Institute.
[31] C. Plass,et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] P. Ladenson,et al. Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. , 2003, Cancer research.
[33] M. Stroun,et al. Circulating nucleic acids in plasma or serum. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[34] S. Filetti,et al. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. , 2001, European journal of endocrinology.
[35] C. Shriver,et al. Expression of the Sodium Iodide Symporter and Thyroglobulin Genes Are Reduced in Papillary Thyroid Cancer , 2001, Modern Pathology.
[36] F. O. Fackelmayer,et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.
[37] M. Yatin,et al. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status. , 1999, The Journal of clinical endocrinology and metabolism.
[38] O. Sheils,et al. TSH receptor status of thyroid neoplasms—TaqMan RT‐PCR analysis of archival material , 1999, The Journal of pathology.
[39] K. Iczkowski,et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. , 1998, Pancreas.
[40] N. Dalay,et al. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy , 2008, Clinical chemistry and laboratory medicine.
[41] M. Fleischhacker,et al. Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.
[42] F. Borson‐Chazot,et al. 0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(5):3028–3035 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1394 Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations , 2022 .